112463-58-8

Upstream product

• 1144097-41-5 C₁₉H₂₁N₃O₅ 

Downstream Products

• 1144097-91-5 3-phenyl-5-[(3,4,5-trimethoxyphenyl)(3-methoxyphenylhydrazono)methyl][1,2,4]-triazin-6(1H)-one 
• 1144097-88-0 3-phenyl-5-[(3,4,5-trimethoxyphenyl)(2-methoxyphenylhydrazono)methyl][1,2,4]-triazin-6(1H)-one 
• 1144097-99-3 3-phenyl-5-[(3,4,5-trimethoxyphenyl)(4-chlorophenylhydrazono)methyl][1,2,4]-triazin-6(1H)-one 
• 1144097-94-8 3-phenyl-5-[(3,4,5-trimethoxyphenyl)(4-methoxyphenylhydrazono)methyl][1,2,4]-triazin-6(1H)-one 
• 1144097-85-7 3-phenyl-5-[(3,4,5-trimethoxyphenyl)(phenylhydrazono)methyl][1,2,4]-triazin-6(1H)-one 
• 1144097-97-1 3-phenyl-5-[(3,4,5-trimethoxyphenyl)(3,4,5-trimethoxyphenylhydrazono)methyl][1,2,4]-triazin-6(1H)-one 

Relevant academic research and scientific papers

Cyclocondensation reaction of heterocyclic carbonyl compounds, Part XIII: Synthesis and cytotoxic activity of some 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines

A series of the 3,7-diaryl-5-(3,4,5-trimethoxyphenyl)pyrazolo[4,3-e][1,2,4]triazines (17a-20f) have been synthesized in five steps. The cytotoxic activity of all of the newly synthesized compounds has been tested in vitro against five cancer cell lines. S